Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. The company has been gaining significant ...

In conclusion, Axsome Therapeutics presents a compelling investment case with its strong commercial performance and promising pipeline. According to InvestingPro's Fair Value analysis, the stock ...

In conclusion, Axsome Therapeutics presents a compelling investment case with its strong commercial performance and promising pipeline. According to InvestingPro's Fair Value analysis, the stock ...

Axsome Therapeutics, Inc. NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

The lawsuit names Courtney Burgess, a one-time music industry bit player, his lawyer and the owner of the cable network NewsNation, which aired an interview with Mr. Burgess. By Julia Jacobs Sean ...

Combs alleged that Courtney Burgess, his lawyer and NewsNation deliberately fabricated and amplified false claims about him for financial gain Paras Griffin/Getty Sean "Diddy" Combs has filed a $ ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Investors in Axsome Therapeutics Inc (Symbol: AXSM) saw new options become available this week, for the September 19th expiration. One of the key data points that goes into the price an option ...